Clinical trial
Global Lomitapide Pregnancy Exposure Registry
NCT02399839 is registered in ClinicalTrials.gov with Amryt Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Global Lomitapide Pregnancy Exposure Registry
- Lead sponsor
- Amryt Pharma
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 31, 2014
- Completion date
- December 31, 2022
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pregnancy